These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30513034)

  • 21. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes.
    Bock KW; Schrenk D; Forster A; Griese EU; Mörike K; Brockmeier D; Eichelbaum M
    Pharmacogenetics; 1994 Aug; 4(4):209-18. PubMed ID: 7987405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
    Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
    Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism.
    Djordjevic N; Ghotbi R; Jankovic S; Aklillu E
    Eur J Clin Pharmacol; 2010 Jul; 66(7):697-703. PubMed ID: 20390257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients.
    Ghotbi R; Mannheimer B; Aklillu E; Suda A; Bertilsson L; Eliasson E; Osby U
    Eur J Clin Pharmacol; 2010 May; 66(5):465-74. PubMed ID: 20143052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6.
    Ellingrod VL; Schultz SK; Arndt S
    Pharmacotherapy; 2002 Nov; 22(11):1416-9. PubMed ID: 12432967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis.
    Tian DD; Natesan S; White JR; Paine MF
    Clin Transl Sci; 2019 Jan; 12(1):39-46. PubMed ID: 30387917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cigarette smoking has a differential effect on the plasma level of clozapine in Taiwanese schizophrenic patients associated with the CYP1A2 gene -163A/C single nucleotide polymorphism.
    Huang HC; Lua AC; Wu LS; Wu BJ; Lee SM; Liu CZ
    Psychiatr Genet; 2016 Aug; 26(4):172-7. PubMed ID: 27203225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjects.
    Hu M; Yang YL; Fok BS; Chan SW; Chu TT; Poon EW; Yin OQ; Lee VH; Tomlinson B
    Drug Metabol Drug Interact; 2012 Jan; 27(1):33-9. PubMed ID: 22718623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).
    Kurylev AA; Brodyansky VM; Andreev BV; Kibitov AO; Limankin OV; Mosolov SN
    Psychiatr Danub; 2018 Jun; 30(2):157-163. PubMed ID: 29930225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status.
    Bågeman E; Ingvar C; Rose C; Jernström H
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):895-901. PubMed ID: 18398030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?
    Dahl ML
    Clin Pharmacokinet; 2002; 41(7):453-70. PubMed ID: 12083975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients.
    Yan P; Song M; Gao B; Wang S; Wang S; Li J; Fang H; Wang C; Shi J
    Psychiatry Res; 2020 Nov; 293():113470. PubMed ID: 32992097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone plasma levels, clinical response and side-effects.
    Riedel M; Schwarz MJ; Strassnig M; Spellmann I; Müller-Arends A; Weber K; Zach J; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):261-8. PubMed ID: 15565299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia.
    Matsumoto C; Ohmori O; Shinkai T; Hori H; Nakamura J
    Psychiatr Genet; 2004 Dec; 14(4):209-13. PubMed ID: 15564895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer.
    Pavanello S; Mastrangelo G; Placidi D; Campagna M; Pulliero A; Carta A; Arici C; Porru S
    Eur J Epidemiol; 2010 Jul; 25(7):491-500. PubMed ID: 20559687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.
    Perera V; Gross AS; Polasek TM; Qin Y; Rao G; Forrest A; Xu J; McLachlan AJ
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1115-37. PubMed ID: 23641727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
    Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
    Kootstra-Ros JE; Smallegoor W; van der Weide J
    Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis.
    Na Takuathung M; Hanprasertpong N; Teekachunhatean S; Koonrungsesomboon N
    Acta Psychiatr Scand; 2019 Jan; 139(1):15-25. PubMed ID: 30112761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.